Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Self-Help manual ease the stress of stem cell transplants?

NCT ID NCT02928185

Knowledge-focused Sponsor: Memorial Sloan Kettering Cancer Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether patients and caregivers find 'Coping Together' manuals helpful after a stem cell transplant. 41 participants shared their thoughts on the manuals during the first 100 days after transplant. The goal was to improve these self-directed coping guides for future use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

41 people

The number who actually took part.

Started

Sep 2016

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Hematopoietic Stem Cell Transplantation and Their Caregivers at MSKCC

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Part 1 HSCT Patients * Admission to the MSKCC Adult BMT service for an outpatient HSCT for a hematologic malignancy * HSCT procedure scheduled within two months of consent * ≥18 years old * Ability to read, speak and understand English * Able to give written informed consent * Physically and cognitively able to participate in the study as determined by the investigators HSCT CGs * ≥18 years old * Ability to read, speak and understand English * Able to give written informed consent * Physically and cognitively able to participate in the study as determined by the investigators HSCT Dyads * In addition to meeting the inclusion criteria for HSCT Patients and HSCT CGs above, both parties must provide mutual agreement to participate as a dyad. HSCT Clinicians * Member of MSKCC BMT patient care team for at least one year Part 2 HSCT Patients * Same as Part 1 HSCT Patients HSCT CGs * Same as Part 1 HSCT CGs HSCT Dyads * Same as Part 1 HSCT Dyads Exclusion Criteria: Part 1 HSCT Patients * Physically and cognitively unable to participate in the study as determined by the investigators HSCT CGs * Inability to complete role responsibilities 24 hours per day for at least 50% of time (50 days) * Physically and cognitively unable to participate in the study as determined by the investigators HSCT Dyads * Participants must not meet the exclusion criteria for HSCT Patients and HSCT CGs above. * Patients or CGs who are participating in this study as individuals HSCT Clinicians * There are no exclusion criteria Part 2 HSCT Patients * Same as Part 1 HSCT Patients HSCT CGs * Same as Part 1 HSCT CGs HSCT Dyads * Same as Part 1 Dyads

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hematologic malignancy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

disease related to hematopoietic stem cell transplant hematopoietic and lymphoid cell neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Post hematopoietic stem cell transplantation

Contacts and locations

Locations

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.